| JXHL2000125 | BI 1701963 片 | BI 1701963 | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-06-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-06-04 | view |
| JXHL2000124 | BI 1701963 片 | BI 1701963 | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-06-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-06-04 | view |
| JXHL2100015 | BI 425809 片 | iclepertin | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-01-16 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-15 | view |
| JXHL2000335 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXHL2000339 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXHL2000357 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000338 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXHL2000356 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000359 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000337 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXHL2000360 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000358 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-01-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000336 | BI 456906 注射液 | survodutide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXSL2000161 | BI 905711输注用粉末 | BI 905711 | Lyophilized | Biological Products(1) | Import Drug Application | 2020-09-27 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-09-25 | view |
| JXSL2000012 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL1900079 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2019-09-11 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2019-09-10 | view |
| JXSL2000006 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSB2000053 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXSL2000011 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JYSB2000191 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-05-23 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-05-22 | view |
